Literature DB >> 16937101

Fixed drug eruption induced by an iodinated non-ionic X-ray contrast medium: a practical approach to identify the causative agent and to prevent its recurrence.

Ingrid Böhm1, Jesus Medina, Pilar Prieto, Wolfgang Block, Hans H Schild.   

Abstract

We describe the case of a 61-year-old physician who developed a fixed drug eruption (FDE) after i.v. administration of a non-ionic monomeric iodinated X-ray contrast medium (CM) (iopromide). During CM injection, a sensation of heat occurred, which was most intense in the right inguinal region. Four hours later, the FDE arose with a red macule of approximately 2 cm in diameter covering a dermal infiltration in the right inguinal region, and enlarged up to a final size of 15 x 8 cm, accompanied by a burning sensation. The patient's history revealed a similar reaction in the same localization and of the same clinical appearance after CM injection 1 year before. Patch testing 4 months later revealed positive reactions to iomeprol and iohexol. Iopamidol injection for another CT examination 23 months later was well tolerated. Based on these results, we suggest patch testing after CM-induced FDE, which could help to select a CM for future CT examinations. Late onset of adverse CM reactions may manifest as FDE. Patch testing within the previous skin reaction area is the diagnostic tool that should be used to confirm the suspected agent, possible cross-reacting agents and well-tolerated agents.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16937101     DOI: 10.1007/s00330-006-0371-6

Source DB:  PubMed          Journal:  Eur Radiol        ISSN: 0938-7994            Impact factor:   5.315


  25 in total

Review 1.  Delayed allergy-like reactions to X-ray contrast media: mechanistic considerations.

Authors:  C Christiansen; W J Pichler; T Skotland
Journal:  Eur Radiol       Date:  2000       Impact factor: 5.315

2.  Early and late reactions after the use of iopamidol 340, ioxaglate 320, and iodixanol 320 in cardiac catheterization.

Authors:  A G Sutton; P Finn; E D Grech; J A Hall; M J Stewart; A Davies; M A de Belder
Journal:  Am Heart J       Date:  2001-04       Impact factor: 4.749

Review 3.  Pathophysiology of fixed drug eruption: the role of skin-resident T cells.

Authors:  Tetsuo Shiohara; Yoshiko Mizukawa; Yuichi Teraki
Journal:  Curr Opin Allergy Clin Immunol       Date:  2002-08

4.  Multiple fixed drug eruption caused by iomeprol (Iomeron), a nonionic contrast medium.

Authors:  H Watanabe; H Sueki; T Nakada; M Akiyama; M Iijima
Journal:  Dermatology       Date:  1999       Impact factor: 5.366

5.  Frequency of late allergy-like adverse reactions following injection of intravascular non-ionic contrast media. A retrospective study comparing a non-ionic monomeric contrast medium with a non-ionic dimeric contrast medium.

Authors:  J Rydberg; J Charles; P Aspelin
Journal:  Acta Radiol       Date:  1998-05       Impact factor: 1.990

6.  Fixed eruption and fever after urography.

Authors:  A E Good; E Novak; L P Sonda
Journal:  South Med J       Date:  1980-07       Impact factor: 0.954

7.  Fixed drug eruption caused by iopamidol, a contrast medium.

Authors:  R Yamauchi; A Morita; T Tsuji
Journal:  J Dermatol       Date:  1997-04       Impact factor: 4.005

8.  Topical provocation of fixed drug eruption. A study of 30 patients.

Authors:  K Alanko
Journal:  Contact Dermatitis       Date:  1994-07       Impact factor: 6.600

Review 9.  Late adverse reactions to intravascular iodinated contrast media.

Authors:  Judith A W Webb; Fulvio Stacul; Henrik S Thomsen; Sameh K Morcos
Journal:  Eur Radiol       Date:  2002-09-10       Impact factor: 5.315

10.  Late phase allergic reaction to a CT contrast medium (iotrolan).

Authors:  T Kanzaki; H Sakagami
Journal:  J Dermatol       Date:  1991-09       Impact factor: 4.005

View more
  9 in total

1.  Protective effect against repeat adverse reactions to iodinated contrast medium: Premedication vs. changing the contrast medium.

Authors:  Shoko Abe; Hozumi Fukuda; Kimiko Tobe; Kenji Ibukuro
Journal:  Eur Radiol       Date:  2015-10-01       Impact factor: 5.315

2.  Letter to the editor: Diagnostic procedures and case related information in ICM-induced hypersensitivity.

Authors:  Ingrid Böhm
Journal:  Br J Radiol       Date:  2011-07       Impact factor: 3.039

3.  30 years of Katayama's article on ionic and non-ionic contrast media: appreciation of well and less known facts of a milestone paper.

Authors:  Ingrid B Böhm
Journal:  Quant Imaging Med Surg       Date:  2020-12

Review 4.  Radiocontrast Media Hypersensitivity Reactions in Children.

Authors:  Francesca Saretta; Silvia Caimmi; Francesca Mori; Annamaria Bianchi; Paolo Bottau; Giuseppe Crisafulli; Fabrizio Franceschini; Lucia Liotti; Claudia Paglialunga; Giampaolo Ricci; Carlo Caffarelli
Journal:  Medicina (Kaunas)       Date:  2022-04-05       Impact factor: 2.948

5.  Contrast-media-induced hypersensitivity or allergic/allergic-like reactions? Suggestion for a more appropriate use of the nomenclature.

Authors:  Ingrid Böhm; Hans Schild
Journal:  Eur J Clin Pharmacol       Date:  2008-08-06       Impact factor: 2.953

6.  Contrast-induced generalized bullous fixed drug eruption resembling Stevens-Johnson syndrome.

Authors:  Meredith Gavin; Leigha Sharp; Kendra Walker; Emily Behrens; Russell Akin; Cloyce L Stetson
Journal:  Proc (Bayl Univ Med Cent)       Date:  2019-08-07

7.  Fixed Drug Eruption due to Iopromide (Ultravist®).

Authors:  Sang Hee Cha; Hei Sung Kim; Jun Young Lee; Hyung Ok Kim; Young Min Park
Journal:  Ann Dermatol       Date:  2011-09-30       Impact factor: 1.444

8.  Galcanezumab-induced fixed drug eruption.

Authors:  Skylar Klager; Marina Khalil; Kenneth Shulman; Naveed Sami
Journal:  JAAD Case Rep       Date:  2021-01-30

Review 9.  The Role of Patch Testing in Evaluating Delayed Hypersensitivity Reactions to Medications.

Authors:  Carina M Woodruff; Nina Botto
Journal:  Clin Rev Allergy Immunol       Date:  2022-02-03       Impact factor: 10.817

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.